Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada.
Lougheed
M Diane
MD
Department of Medicine, Queen's University, Kingston, Ontario, Canada. mdl@queensu.ca
Lemiere
Catherine
C
Dell
Sharon
S
Ducharme
Francine
F
Fitzgerald
J Mark
JM
Leigh
Richard
R
Licskai
Chris
C
Rowe
Brian H
BH
Bowie
Dennis
D
Becker
Allan
A
Boulet
Louis-Philippe
LP
D000293:Adolescent; D058666:Adrenergic beta-2 Receptor Agonists / Q000009:adverse effects* / Q000627:therapeutic use*; D000328:Adult; D000367:Age Factors; D001249:Asthma / Q000188:drug therapy*; D002170:Canada; D002648:Child; D003692:Delayed-Action Preparations; D006801:Humans; D012955:Societies, Medical; D014481:United States; D014486:United States Food and Drug Administration; D055815:Young Adult
D058666:Adrenergic beta-2 Receptor Agonists; D003692:Delayed-Action Preparations